Pharmacon SRL
The score of Pharmacon shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -29 % Total assets -29 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacon's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −33,237 € | ||||
| Equity | 275,949 € | ||||
| Cash | 6,969 € | ||||
| EBITDA | −19,438 € | ||||
| Total assets | 440,606 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 16 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Pharmacon's financial analysis
- Solvency62.6%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacon
Pharmacon's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0457.066.176
- VAT number
- BE0457066176
- Peppol
- Registered · 0208:0457066176 · as of 31 Oct 2026
- Legal form
- SRL
- Incorporated
- 29 Jan 1996
- Registered office
- 9000 Ghent
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Pharmacon (SRL) has been based in Ghent since 1996, active in: business and other management consultancy activities. For 2025, it reports a net loss of 33,237 € and equity of 275,949 €; its revenue is not published. Its solvency stands at 62.6%, above the median of its sector (58.4%).
Companies similar to Pharmacon
Companies in the same business, of comparable size and area, outside its group.
- Milucas Consulting Business and other management consultancy activities Kampenhout · balance sheet 440,611 €
- Minsaer.Consult Business and other management consultancy activities Brecht · balance sheet 440,624 €
- 3yardsMT Business and other management consultancy activities Sint-Katelijne-Waver · balance sheet 440,667 €
- DE PAUW Management Consulting & Training Business and other management consultancy activities Zottegem · balance sheet 440,449 €
- Rowi Consult Business and other management consultancy activities Genk · balance sheet 440,788 €
- Food Consulting 2000 Agency Business and other management consultancy activities Zwalm · balance sheet 440,323 €
- Ammax Business and other management consultancy activities Erpe-Mere · balance sheet 440,924 €
- LA-F Immo Business and other management consultancy activities Frameries · balance sheet 440,245 €
Frequently asked questions about Pharmacon
What is the revenue of Pharmacon?
Pharmacon files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacon?
In Belgium, the VAT number is the company number prefixed with BE: BE0457066176 for Pharmacon, if the company is VAT-registered. Its company number (CBE) is 0457.066.176.
Where is the registered office of Pharmacon?
According to the CBE register, the registered office of Pharmacon is in 9000 Ghent.
What is the equity of Pharmacon?
At the close of the 2025 financial year, the equity of Pharmacon amounts to 275,949 €, a solvency of 62.6% of total assets.
Who manages Pharmacon?
The register lists 1 active mandates at Pharmacon. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacon
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →